Dermatology and Venereology

Uzm. Dr. Ayris Öztürk

Doctor and researcher İzmir Şehir Hastanesi İzmir
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyDermatology and Venereologysaglik.gov.trFrom source
  • Department name at the sourceDeri ve Zührevi Hastalıklarsaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Publications13 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0003-0760-9292ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1569651/doktorlarimiz.html#ayris-ozturksaglik.gov.tr

Scientific work

Publications

13 publications

  1. The Impact of Hidradenitis Suppurativa on Sexual Function: A Multicentered Cross‐Sectional Study

    International Journal of Dermatology, 2026

    DOI 10.1111/ijd.70522 PMID 42268671 Open-access full textSource: ORCID

  2. Clinical Effectiveness and Tolerability of Apremilast in Moderate-to-Severe Plaque Psoriasis: Insights from Real-World Practice Moderate-to-Severe Plaque Psoriasis: Insights from Real-World Practice

    OSMANGAZİ JOURNAL OF MEDICINE, 2026

    DOI 10.20515/otd.1896501 Open-access full textSource: ORCID

  3. Is Omalizumab Monotherapy Sufficient in Chronic Spontaneous Urticaria? Clinical Predictors of Treatment Insufficiency in a Cross-Sectional Cohort

    Journal of Cosmetics Dermatological Sciences and Applications, 2026

    DOI 10.4236/jcdsa.2026.162002 Open-access full textSource: OpenAlex

  4. Paradoxical pityriasis rubra pilaris during adalimumab therapy in juvenile idiopathic arthritis

    Turkish Journal of Pediatric Disease, 2026

    DOI 10.12956/tjpd.2026.1370 Open-access full textSource: ORCID

  5. Sekonder İmmün Yetmezliklerde İmmünglobulin Replasman Tedavisi: Dermatolojik Durumlarda

    A'dan Z'ye Primer ve Sekonder İmmün Yetmezliklerde İmmünglobulin Tedavisi, 2026

    Source: ORCID

  6. PATIENT-REPORTED OUTCOME MEASURES AND QUALITY OF LIFE IN HAIR DISORDERS

    Turkiye Klinikleri eBooks, 2026

    DOI 10.5336/978-625-91141-0-1_p271 Source: ORCID

  7. Comparative efficacy of 1064 nm Q-Switched Nd:YAG laser and microneedling in treating atrophic acne scars: a retrospective study

    Journal of Cosmetic and Laser Therapy, 2025

    DOI 10.1080/14764172.2026.2651542 PMID 41911520 Source: ORCID

  8. Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study

    International Journal of Dermatology, 2025

    DOI 10.1111/ijd.17868 PMID 40400092 Open-access full textSource: ORCID

  9. Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06442-7 PMID 40524021 Open-access full textSource: ORCID

  10. Long-Term Outcomes of Surgical and Chemical Matricectomy for Ingrown Toenail Management: A Retrospective Study

    Dermatology Practical & Conceptual, 2025

    DOI 10.5826/dpc.152a4883 Source: ORCID

View all 13 publications